Active Pharmaceutical Ingredients (API) Market

1
Global Active Pharmaceutical Ingredients (API)
Market to Grow on the Back of Increasing
Prevalence of Chronic Diseases Worldwide Market
to Grow with a CAGR of 6.08 During 2021-
2030 Kenneth Research has released a report
titled Active Pharmaceutical Ingredients (API)
Market Global Demand Analysis Opportunity
Outlook 2030 which also includes some of the
prominent market analyzing parameters such as
industry growth drivers, restraints, supply and
demand risk, along with the impact of COVID-19
and a detailed discussion on the latest trends
and future opportunities that are associated
with the growth of the market. In one of the
statistics by the World Health Organization
(WHO), around 17.9 Million people in the year
2019, died from cardiovascular diseases (CVDs),
while 1.5 Million deaths were caused due to
diabetes in the same year. Moreover, in the year
2020, cancer accounted for around 10 Million
deaths. Get a Sample Copy of this Report with
Graphs and Charts - https//www.kennethresearch.
com/sample-request-10352347 The statistics
portray the growing prevalence of different types
of chronic diseases worldwide, which is driving
the need amongst the pharmaceutical drug
manufacturers for advanced drug ingredients which
can help them in formulating drugs that can
treat these diseases. Active pharmaceutical
2
ingredients (APIs) are an important
component in modern day
pharmaceutical drug manufacturing and are widely
preferred by pharmaceutical drug manufacturers
owing to the numerous benefits associated with
these ingredients. Besides this, the surge in
demand for generic and biosimilar drugs are also
expected to create numerous growth opportunities
for the growth of the global active
pharmaceutical ingredients (API) market in the
coming years. The global active pharmaceutical
ingredients (API) market is anticipated to grow
with a CAGR of 6.08 over the forecast period,
i.e., 2021 2030. The market is estimated to
garner a revenue of USD 331.37 Billion by the end
of 2030. Moreover, in the year 2020, the market
generated a revenue of USD 185.23 Billion. The
market is segmented by therapeutic application
into communicable disease, oncology,
diabetes, cardiovascular disease, musculoskel
etal disorders, respiratory disorders,
and other therapeutic applications. The
cardiovascular disease segment, out of all the
other segments, is anticipated to garner the
largest revenue of USD 68.81 Billion by the end
of 2030. Moreover, the segment generated a
revenue of USD 39.50 Billion in the year
2020. By region, the global active
pharmaceutical ingredients (API) market is
segmented into five major regions including North
America, Europe, Asia Pacific, Latin America and
Middle East Africa. The market in North
America, out of the market in all the other
regions, is anticipated to garner the largest
revenue of USD 127.61 Billion by the end of 2030.
Additionally,
3
the market in the region generated a revenue of
USD 71.70 Billion in the year 2020. The
research is global in nature and covers detailed
analysis on the market in North America (U.S.,
Canada), Europe (U.K., Germany, France, Italy,
Spain, Hungary, Belgium, Netherlands
Luxembourg, NORDIC Finland, Sweden, Norway,
Denmark, Poland, Turkey, Russia, Rest of
Europe), Latin America (Brazil, Mexico,
Argentina, Rest of Latin America), Asia-Pacific
(China, India, Japan, South Korea, Indonesia,
Singapore, Malaysia, Australia, New Zealand,
Rest of Asia-Pacific), Middle East and Africa
(Israel, GCC Saudi Arabia, UAE, Bahrain,
Kuwait, Qatar, Oman, North Africa, South
Africa, Rest of Middle East and Africa). In
addition, analysis comprising market size, Y-O-Y
growth opportunity analysis, market players
competitive study, investment opportunities,
demand for future outlook etc. has also been
covered and displayed in the research
report. However, the high cost of manufacturing
of APIs is one of the major factors predicted to
hinder the market growth in the coming
years. This report also provides the existing
competitive scenario of some of the key players
of the global active pharmaceutical ingredients
(API) market, which includes company profiling
of Pfizer Inc., GlaxoSmithKline plc, Novartis AG,
Sanofi-aventis Groupe, Boehringer Ingelheim
International GmbH, Aurobindo Pharma, Dr.
Reddys Laboratories Ltd., API Corporation,
Bristol- Myers Squibb Company, KATSURA CHEMICAL
CO., LTD., and others. The profiling enfolds key
information of the companies which comprises of
business overview, products and services, key
financials and recent news and
4
developments. Conclusively, the report titled
Active Pharmaceutical
Ingredients (API) Market Opportunity Outlook 203
0,
Demand Analysis the overall global active
Global analyses industry
pharmaceutical ingredients (API)
to help new entrants to
understand the details of the market. In addition
to that, this report also guides existing
players looking for expansion and major investors
looking for investment in the global active
pharmaceutical ingredients (API) market in the
near future. Download Free Sample Reports Here
- https//www.kennethresearch.com/sample-request-
10352347 Kenneth Research is a leading service
provider for strategic market research and
consulting. We aim to provide unbiased,
unparalleled market insights and industry
analysis to help industries, conglomerates and
executives to take wise decisions for their
future marketing strategy, expansion and
investment, etc. We believe every business can
expand to its new horizon, provided a right
guidance at a right time is available through
strategic minds. Our out of box thinking helps
our clients to take wise decision so as to avoid
future uncertainties. Contact for more Info AJ
Daniel Email sales_at_kennethresearch.com U.S.
Phone [phone]